Co-Diagnostics Inc is a biotechnology company that focuses on the development and manufacturing of molecular diagnostic tests used to detect diseases. The company specializes in the design of innovative testing solutions that leverage its proprietary technologies for amplification and detection of nucleic acids. Co-Diagnostics aims to provide accurate and timely diagnostic tools that facilitate the identification of various pathogens, aiding in disease prevention and management. Through its commitment to enhancing diagnostic capabilities, the company supports healthcare providers and public health initiatives. Read More
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Co-Diagnostics (CODX) Q2 2025 earnings show revenue beat at $160K but EPS loss of -$0.23. Shares flat post-report as investors await profitability signs.
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
